| Trial ID: | L5603 |
| Source ID: | NCT00798785
|
| Associated Drug: |
Atg-Mmf-Tac
|
| Title: |
Long-term Function of Beta Cell Allografts in Non-uremic Type 1 Diabetic Patients
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 1
|
| Interventions: |
DRUG: ATG-MMF-TAC|DRUG: ATG-Rituximab-MMF-TAC|DRUG: ATG-basilixumab-MMF-TAC|PROCEDURE: omentum
|
| Outcome Measures: |
Primary: Evidence of clinically relevant beta cell graft function, up to 60 months |
|
| Sponsor/Collaborators: |
Sponsor: AZ-VUB
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1|PHASE2
|
| Enrollment: |
50
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2006-10
|
| Completion Date: |
2014-12
|
| Results First Posted: |
|
| Last Update Posted: |
2013-12-30
|
| Locations: |
Universitair Ziekenhuis Antwerpen, Antwerpen, Belgium|University Hospital Brussels, Brussels, 1090, Belgium|Hopital Erasme, Brussel, Belgium|University Hospital Leuven, Leuven, 3000, Belgium
|
| URL: |
https://clinicaltrials.gov/show/NCT00798785
|
